These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 23257365)

  • 41. Association of clinical benign prostate hyperplasia with prostate cancer incidence and mortality revisited: a nationwide cohort study of 3,009,258 men.
    Ørsted DD; Bojesen SE; Nielsen SF; Nordestgaard BG
    Eur Urol; 2011 Oct; 60(4):691-8. PubMed ID: 21705134
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Body mass and survival in patients with chronic heart failure without cachexia: the importance of obesity.
    Davos CH; Doehner W; Rauchhaus M; Cicoira M; Francis DP; Coats AJ; Clark AL; Anker SD
    J Card Fail; 2003 Feb; 9(1):29-35. PubMed ID: 12612870
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Body mass index and the risk of progression of chronic kidney disease.
    Khedr A; Khedr E; House AA
    J Ren Nutr; 2011 Nov; 21(6):455-61. PubMed ID: 21454093
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of obesity on incidence of type 2 diabetes declines with age among Japanese women.
    Fujita M; Ueno K; Hata A
    Exp Biol Med (Maywood); 2009 Jul; 234(7):750-7. PubMed ID: 19429850
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Waist/height ratio as a better predictor of type 2 diabetes compared to body mass index in Tehranian adult men--a 3.6-year prospective study.
    Hadaegh F; Zabetian A; Harati H; Azizi F
    Exp Clin Endocrinol Diabetes; 2006 Jun; 114(6):310-5. PubMed ID: 16868890
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The relationship between the insulin-like growth factor-1 axis, weight loss, an inflammation-based score and survival in patients with inoperable non-small cell lung cancer.
    Meek CL; Wallace AM; Forrest LM; McMillan DC
    Clin Nutr; 2010 Apr; 29(2):206-9. PubMed ID: 19748165
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A prospective study of the role of inflammation in bladder cancer.
    Qayyum T; McArdle P; Hilmy M; Going J; Orange C; Seywright M; Horgan P; Underwood M; Edwards J
    Curr Urol; 2013 Feb; 6(4):189-93. PubMed ID: 24917741
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Willder JM, Walker VC, Halbert GL, et al: Body mass index predicts failure of surgical management in benign prostatic hyperplasia. Urol Int 2013;90:150-155.
    Garg M; Prakash J; Singh V
    Urol Int; 2013; 91(4):486. PubMed ID: 23838669
    [No Abstract]   [Full Text] [Related]  

  • 49. Re: Association between Benign Prostatic Hyperplasia, Body Mass Index, and Metabolic Syndrome in Chinese Men.
    Kaplan SA
    J Urol; 2017 Mar; 197(3 Pt 1):770-772. PubMed ID: 28208548
    [No Abstract]   [Full Text] [Related]  

  • 50. The Obesity Epidemic and Its Impact on Urologic Care.
    Mobley D; Baum N
    Rev Urol; 2015; 17(3):165-70. PubMed ID: 26543431
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Body mass index predicts failure of surgical management in benign prostatic hyperplasia.
    Willder JM; Walker VC; Halbert GL; Dick CP; Orange C; Qayyum T; Horgan PG; Underwood MA; Edwards J
    Urol Int; 2013; 90(2):150-5. PubMed ID: 23257365
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The prognostic use of inflammation and tissue necrosis in benign prostatic hyperplasia.
    Willder JM; Walker VC; Halbert GL; Dick CP; Orange C; Qayyum T; Horgan PG; Underwood MA; Edwards J
    Urol Int; 2013; 91(1):19-25. PubMed ID: 23306308
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Comparison of the prognostic value of inflammation-based pathologic and biochemical criteria in patients undergoing potentially curative resection for colorectal cancer.
    Roxburgh CS; Salmond JM; Horgan PG; Oien KA; McMillan DC
    Ann Surg; 2009 May; 249(5):788-93. PubMed ID: 19387324
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Calculated fast-growing benign prostatic hyperplasia--a risk factor for developing clinical prostate cancer.
    Hammarsten J; Högstedt B
    Scand J Urol Nephrol; 2002; 36(5):330-8. PubMed ID: 12487736
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Body size and serum levels of insulin and leptin in relation to the risk of benign prostatic hyperplasia.
    Dahle SE; Chokkalingam AP; Gao YT; Deng J; Stanczyk FZ; Hsing AW
    J Urol; 2002 Aug; 168(2):599-604. PubMed ID: 12131317
    [TBL] [Abstract][Full Text] [Related]  

  • 56.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.